$DXR News
Last published 3w ago
- 3w agoDXRDaxor Accelerates Commercial Expansion of Next-Gen Blood Volume Diagnostic Platform at MedAxiom CV Transforum Fall '26GlobeNewswireFDA-cleared BVA™ technology delivers lab-accurate precision to optimize cardiovascular service lines, reduce 30-day readmissions, and lower cost of care. Key Highlights: Commercial Acceleration: Daxor showcasing its
- 4w agoDXRDaxor Announces Strong Commercial Interest and New Clinical Data at HFSA 2026GlobeNewswireNew Clinical Studies Validate BVA™ Technology in High-Acuity Heart Failure Populations to Enhance Care OAK RIDGE, TN, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood
- 4w agoDXRDaxor to Showcase Blood Volume Analysis Platform at ASN Kidney Week 2026GlobeNewswireMaking its ASN debut, Daxor’s BVA™ technology delivers precise volume measurement to optimize fluid management and improve complex kidney care. Key Highlights: Commercial Presence: Daxor exhibiting at Booth #390
- 2mo agoDXRDaxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth ConferenceGlobeNewswireOak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in
- 2mo agoDXRDaxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder LetterGlobeNewswireOak Ridge, TN, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to
- 3mo agoDXRDaxor Broadens Outpatient Footprint with Initiation of ezBVA Lab Diagnostic Services in KansasGlobeNewswireCommercial Momentum Accelerates as Health System Adopts Turnkey Blood Volume Analysis via CLIA-Certified Send-Out Model OAK RIDGE, TN, July 29, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global
- 4mo agoDXRDaxor Corporation Announces First-Time Exhibition at the 14th Annual Dysautonomia International Conference in The Woodlands, TexasGlobeNewswireDaxor to Showcase How BVA Provides the Objective Plasma and Red Blood Cell Data Needed to Target Dysautonomia Therapy Oak Ridge, TN, July 07, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader
- 5mo agoDXRDaxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume MonitorGlobeNewswireNew Technology Expands Daxor's Diagnostic Capabilities to Enable Continuous, Remote Tracking of Blood Volume Status Using Wearable Sensors, Enhancing Care for Heart Failure, Syncope, Anemia, and Polycythemia OAK RIDGE,
- 6mo agoDXRDaxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume AnalysisGlobeNewswireOak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer (BVA™)
- 7mo agoDXRDaxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology CenterGlobeNewswireOak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a new BVA program at a
- 7mo agoDXRDaxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026GlobeNewswireOAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the accuracy of capillary
- 8mo agoDXRDaxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care CongressGlobeNewswireAdvancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume
- 8mo agoDXRDaxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026GlobeNewswireOak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, announces that CEO and President Michael Feldschuh will participate in the
- 8mo agoDXRDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersGlobeNewswireOak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders filed in its
- 8mo agoDXRDaxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per ShareGlobeNewswireStrategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood Volume Analyzer Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader
- 8mo agoDXRDaxor Scales Outpatient Presence; Launches BVA Diagnostic Program in TennesseeGlobeNewswireExpansion Leverages Daxor's ezBVA Lab to Deliver 98% Accurate Diagnostics with Zero Capital Investment Oak Ridge, TN, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood
- 9mo agoDXRDaxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic BusinessGlobeNewswireOak Ridge, TN, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announced its intention to transition its primary regulatory reporting
- 9mo agoDXRDaxor Corporation Announces $9 Million Registered Direct OfferingGlobeNewswireOAK RIDGE, TN, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NasdaqCM: DXR) ("Daxor" or the "Company") announced today that it has entered into a definitive agreement with fundamental investors for the purchase
- 11mo agoDXRDaxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA AnalyzerGlobeNewswireContinued Integration of ezBVA Lab Service and On-Site Analyzer Deployment Signals Accelerating Market Traction Oak Ridge, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in
- 1y agoDXRDaxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth SummitGlobeNewswireSummit Features a Select Group of 40 Promising Healthcare Companies at Premier Small-Cap Investor Event OAK RIDGE, TN, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood
- 1y agoDXRDaxor's New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25GlobeNewswireOAK RIDGE, Tenn., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces it will be exhibiting at the MedAxiom Cardiovascular (CV)
- 1y agoDXRDaxor Unveils New FDA-Cleared BVA Analyzer Amid Strong Market Demand and Pivotal Clinical Data at HFSAGlobeNewswireThree Studies Validate BVA-Guided Care Significantly Cuts Hospital Readmissions and Boosts Survival in High-Cost Heart Failure Segments OAK RIDGE, TN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR),
- 1y agoDXRDaxor Corporation Unveils Breakthrough Next-Gen BVA Analyzer at HFSA Annual Scientific MeetingGlobeNewswireAdditional New Clinical Data To Be Presented Driving a New Standard of Care in Volume Measurement OAK RIDGE, Tenn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume
- 1y agoDXRDaxor's Blood Volume Analysis Validated for COVID and Sepsis Patients in New Peer-Reviewed Pilot Study Published in the Journal of Critical CareGlobeNewswireStudy Demonstrates That Clinical Assessments of Fluid Status Are Often Inaccurate, Highlighting the Urgent Need for BVA and Other More Reliable Tools in Landmark Pilot Study Oak Ridge, TN, Sept. 04, 2025 (GLOBE
- 1y agoDXRDaxor Corporation to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceGlobeNewswireOak Ridge, TN, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the
- 1y agoDXRDaxor Corporation CEO and President Michael Feldschuh Delivers 1st Half Corporate Update in Shareholder LetterGlobeNewswireOak Ridge, TN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to
- 1y agoDXRDaxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now AvailableGlobeNewswireThe celebration marks a major milestone for the patent-pending, next-generation, rapid, compact, and hand-held Daxor BVA™. Oak Ridge, TN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the
- 1y agoDXRDaxor Corporation Receives FDA Clearance for New Rapid, Lightweight, Blood Volume Analysis SystemGlobeNewswireManagement Expects High Demand Driven by Speed, Simplicity, and Clinical Precision Oak Ridge, TN, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement
- 1y agoDXRDaxor's Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility AdoptionsGlobeNewswireContinued Integration of Daxor's ezBVA Lab Service and On-Site Analyzers Fuels Positive Outlook Oak Ridge, TN, July 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume
- 1y agoDXRDaxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart JournalGlobeNewswirePublished Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak Ridge, TN, May 14, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), Daxor Corporation,
- 1y agoDXRDaxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare SystemsGlobeNewswireGold-Standard Technology Now Available in East Tennessee and Pacific Northwest Through Strategic Dual-Model Implementation Oak Ridge, TN, May 13, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), Daxor
- 1y agoDXRFlorida Healthcare Leader Embraces Daxor Blood Volume Analysis TechnologyGlobeNewswireDaxor's ezBVA Lab Service Marks New Standard in Precision Fluid Management Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology,
- 1y agoDXRThree New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical AcceptanceGlobeNewswireDaxor's Innovative ezBVA Lab Service Drives Accessibility and Operational Efficiency Oak Ridge, TN, May 06, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement
- 1y agoDXRDaxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific SessionsGlobeNewswireDaxor Brings Advanced Blood Volume Analysis Solutions to Elite Heart and Lung Transplantation Forum Oak Ridge, TN, April 22, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume
- 1y agoDXRDaxor Corporation to Showcase Innovative Blood Volume Analysis at MedAxiom Cardiovascular Transforum Spring 2025GlobeNewswireWellStar Health System to Highlight New BVA-Driven Strategy That Significantly Reduces Kidney Injury Following LVAD Implantation Oak Ridge, TN, April 17, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the
- 1y agoDXRNew Research at ACC25 Shows Daxor BVA-Identified Euvolemic Heart Failure Patients Experience 2.61 Times Better SurvivalGlobeNewswirePrecise Volume Measurement Prior to Discharge Identifies Mortality Risk Oak Ridge, TN, April 15, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today
- 1y agoDXRDaxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume AnalyzerGlobeNewswireAdvanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), a leader in blood volume measurement technology, announces today the
- 1y agoDXRDaxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and ExpoGlobeNewswireBVA and Pressure Session Attracted 400+ Clinicians; Duke University Showcased Valuable New BVA Findings in Dedicated Poster Presentation Oak Ridge, TN, April 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation
- 1y agoDXRDaxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare NetworksGlobeNewswireRegional Medical Leaders Embrace Daxor's ezBVA Lab Service Oak Ridge, TN, March 28, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), Daxor, the global leader in blood volume measurement technology, today
- 1y agoDXRDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2024GlobeNewswireStrong Start to 2025 with Unaudited Revenue Increases Leading to Cash Flow Positive Operating Company Results Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in
- 1y agoDXRDaxor Corporation to Host Investor Conference Call to Discuss Fiscal Year 2024 Financial Results and Provide a Corporate Update on March 6, 2025GlobeNewswireOak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology, today announces it will host an investor conference call on Thursday, March 6,
- 1y agoDXRDaxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersGlobeNewswireOak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders filed in its
- 1y agoDXRDaxor Corporation Reports Increase in NAV to $7.25 Per Share and 116.5 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023GlobeNewswireStrong Start to 2025 with Unaudited Revenue Increases Leading to Cash Flow Positive Operating Company Results Oak Ridge, TN, March 04, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in
- 1y agoDXRDaxor Expands Blood Volume Analysis Services at Major Midwest Healthcare CenterGlobeNewswirePremier 735-Bed Healthcare Facility Implements ezBVA Lab Service to Enhance Cardiovascular Outpatient Care Oak Ridge, TN, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), Daxor, the global leader in
- 1y agoDXRDaxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey HospitalsGlobeNewswireLeading Academic Health System Adopts Daxor's Innovative Blood Volume Measurement Capabilities at Two Key Facilities Oak Ridge, TN, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader
- 1y agoDXRDaxor Corporation Announces New Data on Blood Volume Analysis from Duke and Yale Universities Presented at THT 2025GlobeNewswireTwo Groundbreaking Studies on Fluid Management: Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge Oak Ridge, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the
- 1y agoARDTDXRTruLite Health Bolsters Health Equity Expertise with Expanded Leadership TeamBusiness WireNewly appointed President Walter D. Conwell, MD, MBA, poised to broaden reach with healthcare organizations nationwide Two board members bring additional expertise in health equity innovation and
- 1y agoDXRDaxor to Exhibit at World's Largest Critical Care ConferenceGlobeNewswireDaxor's Blood Volume Analysis (BVA) Technology Takes Center Stage at SCCM 2025 Oak Ridge, TN, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement technology,
- 1y agoDXRDaxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted TreatmentGlobeNewswireCase Reports in the Journal of the American College of Cardiology Underscore the Critical Role of Blood Volume Analysis in Optimizing Heart Failure Treatment Oak Ridge, TN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Daxor
- 1y agoDXRNew Multicenter Study Highlights Utility of Daxor's Blood Volume Analysis in Heart Failure CareGlobeNewswireResearch Published in the Prestigious Journal of Cardiac Failure From Three Institutions Oak Ridge, TN, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ:DXR), the global leader in blood volume measurement